Navigation Links
Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism

The thyroid hormone replacement prescription drug, levothyroxine sodium (Unithroid) for hypothyroidism in adults and children has been approved for use in the United States by the FDA.

The thyroid hormaone is involved in the regulation of a wide range of metabolic processes within the body in all age groups. In children thyroid hormones are essential for normal physical growth and intellectual development.

Low levels of thyroid hormone or hypothyroidism may be due to a birth defect for examole partial or complete absence of the thyroid gland or it may occur later in life due in conditions such as thyroiditis, goiter, or on surgical removal of the thyroid gland.

Other or previously-used medications, such as Synthroid, Cytomel, Euthyroid, Thyrolar, and Armour Thyroid, are often difficult to control, and sometimes results in symptoms of hyperthyroidism.

Levothyroxine sodium (Unithroid) is identical to a natural thyroid hormone produced by the body.

During initiation of replacement therapy with levothyroxine, blood tests are usually performed every six to eight weeks in adults to aid in dose adjustment. Once the optimal replacement dose of levothryoxine for an individual adult patient is determined, blood tests are usually done less frequently; e.g., every six to twelve months.

Symptoms of hypothyroidism include poor growth in children and, in those born with this disorder, impaired intellectual development if this disorder is not promptly and adequately treated. Symptoms of hypothyroidism in children and adults include fatigue, cold intolerance, dry skin, lethargy and weight gain.
'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Another Cause of Thyroid Cancer Discovered
3. Common Thyroid Problems In Women May Lower Their Risk Of Developing Breast Cancer
4. Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available
5. Risk of Thyroid cancer is increased after Childhood Irradiation of Neck region
6. Endoscopic Thyroidectomy Helps In Removing Thyroid Cysts
7. Differentiated Thyroid Carcinoma Can Widely Infiltrate The Larynx
8. Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine
9. New Study Suggests Perchlorate Effects on Thyroid Function of U.S. Women
10. Levels of Thyroid Hormone Forecasts Life Span
11. Longer-Lived Rodents Have Lower Levels of Thyroid Hormone
Post Your Comments:
(Date:5/22/2008)..., N.C. -- A new study by Duke University researche...O) system in the life of a cell plays a key role i...ve treatment of illnesses such as heart disease an...a major biological signaling pathway that has been...s, and it is linked to cancer and other diseases w...
(Date:5/22/2008)...entation Will be Webcast Live and Archived on Comp...-FirstCall/ -- Vanda Pharmaceuticals,Inc. (Nasdaq:...he development,and commercialization of clinical-s... disorders, today announced that Mihael H. Polymer...r a corporate presentation on,Wednesday, May 28, 2...
(Date:5/22/2008)... BEACH, Calif., May 22 /PRNewswire/ -- Whether you... short getaway, if you are an older adult,there ar...re a healthy,trip. According to Timothy Schwab, M....se ten tips for seniors apply whether you,re plann...s away., 1. Discuss travel plans with your ...
(Date:5/22/2008)...udy suggests threat of starvation triggers the swi...) -- New animal research suggests the body,s biolo... the rise and fall of the sun, can be overridden i..., The finding is based on work with mice and ha...cations are that, when faced with starvation, the ...
Breaking Medicine News(10 mins):Health News:Major 'missed' biochemical pathway emerges as important in virtually all cells 2Health News:Major 'missed' biochemical pathway emerges as important in virtually all cells 3Health News:Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference 2Health News:SCAN Health Plan Offers Seniors Ten Tips for Safe and Healthy Travel 2Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 2Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 3Health News:'Food Clock' May Override Master Sleep Clock in Times of Duress 4
...oral treatment for smoking, called Zyban. The pil...y the first product aimed at stopping smoking and ...wspersons, Mr. Kalyanasundaram, Director (Pharmace...ete treatment osts about Rs. 5000 and takes about ...
... of cancer, is avenged now by the new proven effec...dermal growth factor receptor tyrosine kinase inhi... in patients with advanced non-small cell lung can...ation with standard chemotherapy agents after segm...
...ls of S-nitrosoalbumin, a naturally occuring chemi...ngerous complication of pregnancy affects 10% of a...en into a life threatening condition called Eclamp...ng pregnancy. The research was led by Dr.Valerian...
... embarking on an exercise to grade hospital and me.... Sanjiv Malik, Honorary Secretary-General of the ...nce with ORGMARG to create a database on all the m...it allopathy or homeopathy, he said. The process ...
Other Medicine News:
(Date:5/21/2008)...1 /- Pressure,BioSciences, ... scientists,from the New York University (NYU) Sch... the Harvard School of Public Health made presenta... patented pressure cycling,technology (PCT) at thr....,There were three oral presentations and four pos...
(Date:5/21/2008)...an Urological Association Annual Meeting -, SEATT.../ -- Researchers,from Dendreon Corporation (Nasdaq...rating the potential of D-3263, Dendreon,s orally ...(a transmembrane cation channel protein also,known... (BPH)., The abstract (#2041), "Preclinical Valid...
(Date:5/20/2008)...ay 21 /- Today at the,World...e entitled "New,Perspectives in Atrial Fibrillatio...linical Cardiology, St George,s University of Lond...ced ATHENA clinical trial,results, as the way forw...n, the most common form of cardiac arrhythmia., T...
(Date:5/20/2008)...ed today at Digestive Disease Week -, CAMBRIDGE, ...--,Ironwood Pharmaceuticals, Inc. (formerly Microb...X ) today announced the presentation of data,from ...olled study,assessing the safety and efficacy of l...CC). Analysis of these data indicate that linaclot...
Breaking Medicine Technology:Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 2Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 3Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 2Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 3Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 4Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 5Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 6Nucletron Announces Oncentra 28R 29 Brachy Treatment Planning Solution for Multimodality Environment 4906 1Nucletron Announces Oncentra 28R 29 Brachy Treatment Planning Solution for Multimodality Environment 4906 2Terumo Heart Summarizes Results of DuraHeart 28TM 29 LVAS Implants 1913 1Terumo Heart Summarizes Results of DuraHeart 28TM 29 LVAS Implants 1913 2Will you be misdiagnosed 3F how diagnostic errors happen 17851 1Will you be misdiagnosed 3F how diagnostic errors happen 17851 2Will you be misdiagnosed 3F how diagnostic errors happen 17851 3American Chemical Societys Weekly PressPac April 23 2008 3076 1American Chemical Societys Weekly PressPac April 23 2008 3076 2American Chemical Societys Weekly PressPac April 23 2008 3076 3American Chemical Societys Weekly PressPac April 23 2008 3076 4American Chemical Societys Weekly PressPac April 23 2008 3076 5American Chemical Societys Weekly PressPac April 23 2008 3076 6American Chemical Societys Weekly PressPac April 23 2008 3076 7American Chemical Societys Weekly PressPac April 23 2008 3076 8
...r 7, 2007 - Gemin X,announced today that a report ...od demonstrated that its lead compound, GX15-070,(...inst,patient-derived multiple myeloma tumor cells ...ts when used as a combination therapy.,GX15-070 is... all,relevant members of the Bcl-2 protein family,...
...erican College of,Cardiology,s Scientific Session ...irstCall/ -- CV,Therapeutics, Inc. announced today...N TIMI-36 study of ranolazine shows there was no,a...n ranolazine.,The study did not meet the primary e...,s special protocol assessment,agreement with the ...
Other Medicine Technology:Gemin X Announces Publication of Preclinical Data of GX15-070 in,Multiple Myeloma in Blood 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 3
ORTHOSET Radiopaque Bone Cement consists of a two component system: a sterile,ampule containing bone cement liquid within a blister pack, and a sterile polyethylene bag,containing bone cement pow
Low viscosity bone cement without antibiotics for syringe use with an average setting time of approx. 7-9 Min., 40g of powder and 14.6g of liquid.
...eoscope represents new thinking to address common ... eliminating a 5.85 mm diameter outer arthroscope ...diameter Videoscope has superior access and mobili...and especially in the elbow and ankle. In conjunct...
... llifestly of hypertensive and hopotensive patient...sociated with blood pressure monitoring conducted ...ep instrument, it enables physicians to conduct ro...f ther patient's homes. With its built-in proprie...
Medicine Products: